Archive | education & training RSS for this section

Stay-tuned for funding and registration information for the C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology” educational workshop (04-Nov-2017, BC)

C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology” educational workshop will be held on Saturday, 4 November 2017 in Vancouver, BC. The workshop is in response to the C17 DVL needs assessment that was completed last year; members from all C17 DVL sites and PROFYLE clinical site leads are encouraged to attend.

The workshop is a full day, pre-session workshop at the CCRA Canadian Cancer Research Conference. We hope that most attendees at our workshop will take the opportunity to attend the full conference as well.

The workshop will be designed to educate investigators on traditional models of early phase trials as well as newer approaches to drug development. We will also cover regulatory, ethical, advocacy and access aspects of early phase trials. The workshop will proved education, discussions, panels and time for questions.

If our fundraising is successful, our goal is to help provide some funding to C17 DVL participating centres to allow investigators and senior research staff to attend.

Registration will be live next week.

9th Annual Interaction Conference Sept 22-23 in Toronto: an integrated industry and academic conference targeted towards those who manage or direct projects related to oncology clinical trials (www.interaction-canada.ca)

On behalf of my fellow conference organizers, I would like to bring your attention to the ninth annual Interaction Conference – an Academic-Industry Cancer Trials meeting that will be held at the MaRS building in Toronto on September 22-23, 2017. The aim of this conference is to bring together cancer clinical trials staff from academia and pharma for a two day meeting. The meeting is being organized to cater to the needs of clinical trials staff, including project directors, project managers, CRAs, data coordinators, nurses, monitors, regulatory officers and administrators.

Important goals of this meeting are to foster closer cooperation and understanding between academia and pharma staff in the conduct of cancer studies.

Further information and a registration link can be found at www.interaction-canada.ca

Please pass along to others who may be interested. Do not hesitate to contact us with any questions.

I look forward to seeing you in September.

Kind Regards,

Jasmine Grant, MEd, CCRP
Education Specialist Lead
Cancer Clinical Research Unit
Princess Margaret Cancer Centre
(416) 946-4501 x3465
Jasmine.grant@uhn.ca

 

 

YOU HAVE BEEN MISSING OUT, if you are not a part of the CYP-C Research Champions program. [Video & Publication Opportunity]

YOU HAVE BEEN MISSING OUT, if you are not a part of the CYP-C Research Champions program. Please watch our [VIDEO] update and think about joining for opportunities to publish and more! [CYP-RC Publication Policy]

We also have a meeting booked at SIOP in Washington DC (Sunday, October 15 from 13:30 – 17:00), for those in attendance.

Une version française du cours de formation de CITI sur la division 5 est maintenant disponible; les institutions du C17 ont accès via l’inscription du C17 au N2

Remarque: Le C17 est membre N2 (Réseau des Réseau): les institutions du C17 ont accès à toutes les ressources d’enseignement et de formation N2, y compris la formation  CITI.

Le Cours de CITI sur la Division 5: Drogues destinées aux essais cliniques sur des sujets humains de Santé Canada a été traduit en français. Cette traduction a été possible grâce a l’aide financière généreusement offerte par le FRSQ. Vous pouvez y accéder en consultant le site Web de CITI: http://n2canada.us14.list-manage2.com/track/click?u=3701881b24851f487859ab8c8&id=b17362d464&e=33118d4f3d.

The Health Canada Division 5: Drugs for Clinical Trials Involving Human Subjects CITI Course has been translated into a French version. The FRQS has generously provided financial support to make this translation possible. It can now be accessed through the CITI website: http://n2canada.us14.list-manage2.com/track/click?u=3701881b24851f487859ab8c8&id=fc3e54cb50&e=33118d4f3d.

 

SAVE-THE-DATE: C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology” educational workshop (Saturday, 4 November 2017)

C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology educational workshop being held on Saturday, 4 November 2017 in Vancouver, BC. The workshop is in response to the C17 DVL needs assessment that was completed last year as we expanded the C17 DVL network across Canada from 8 to 11 sites. While many investigators and research staff have had experience or education in early phase trials, here was a need identified to provide education and mentorship to research staff conducting early phase trials. With the development of pediatric precision medicine trials in Canada, the need will be even greater.

The workshop is a full day, pre-session workshop at the CCRA Canadian Cancer Research Conference. We hope that most attendees at our workshop will take the opportunity to attend the full conference as well.

The workshop will be designed to educate investigators on traditional models of early phase trials as well as newer approaches to drug development. We will also cover regulatory, ethical, advocacy and access aspects of early phase trials. The workshop will proved education, discussions, panels and time for questions.

Our goal will be to help provide some funding to C17 DVL participating centres to allow investigators and senior research staff to attend.

 

More details will be circulated once available.

 

C17 Education Rounds Videoconference: The Hospital at Home (H@H) Program by Dr. Lucie Lafay-Cousin

The Hospital at Home (H@H) Program at the Alberta Children’s Hospital

Dr. Lucie Lafay-Cousin MD, Pediatric Oncologist, Alberta Children’s Hospital

Wednesday March 15, 2017, 12:00 – 13:15 MST

Objectives:

  1. Describe the H@H initiative
  2. Report on activities and results
  3. Discuss the practical aspects of program development

This event will be recorded by AHS Digital Media Services and will be available to view after the presentation date. 

Telehealth host site: Stollery Children’s Hospital

Telehealth Registration:  Book a room with your institution’s Videoconference Dept. and then follow instructions in the e-mail included with this poster (see e-mail below) in order to register online with Alberta Health Services @ www.vcscheduler.ca/ahs
If you need help please contact our Telehealth team atedm.telehealthscheduling@albertahealthservices.ca

 

To obtain credit certification, please make sure you complete and submit your evaluation form.

Release of CCTCC REB Accreditation WG Final Recommendations & Joint Response by CCTCC & Health Canada

The purpose of this message is to introduce the CCTCC REB Accreditation WG’s Final Recommendations (FRs), and the joint response by the CCTCC and Health Canada (HC) to the FRs.
The full package is available HERE.

CCTCC REB WG FRs:

There are seven FRs in total, aimed at ensuring Canada’s REB competitiveness on a global scale. FR#7, which calls for the establishment of a National Strategic Leadership Forum, is seen as the foundation of the other FRs. The FRs are based on data collected through interviews with key stakeholders in the Canadian and US REB fields as well as consultations and feedback provided by key REB stakeholders in Canada.

Background:

The CCTCC REB Accreditation WG was established in 2015, in collaboration with Health Canada, to identify strategies to improve efficiencies of ethics reviews and advance strategic issues like accreditation in regards to clinical trials. The establishment of the WG is consistent with Recommendation #4 of the Action Plant to Help Attract More Clinical Trials to Canada as well as Recommendation #3 of the Senate Report entitled “Canada’s Clinical Trials Infrastructure: A prescription for Improved Access to New Medicines”.

Given the REB centralization and harmonization initiatives that have been taking place across Canada, the WG, as stated in their Interim Report (IR), did not see formal accreditation scheme as a given. The IR’s key recommendations called for investigating the:

  • impact of these provincial initiatives
  • models of review being adopted by these initiatives,
  • standards and metrics currently being applied to REB operations (in Canada and USA)

The WG proceed with addressing the IR’s recommendations which resulted in the presented/attached FRs.

The contents of the full package include:

  1. Summary of the FRs and joint response by CCTCC and HC
  2. Full text of the FRs
  3. SPOR SHRER Report Committee recommendations – in fulfillment of FR I

CCTCC and Health Canada wish to express their profound gratitude to the members of the REB Accreditation Working Group (WG) and specifically the chair of the WG – Laurel Evans and the co-chair Karine Morine for their continued dedication and invaluable efforts in making the attached report a reality.

Please direct any questions to Elena Aminkova, Interim Director of Project Facilitation, CCTCC by emailing eaminkova@cctcc.ca

Biospecimen Research Methods – UBCx online professional course begins February 15

Enrollment is now open! Class begins February 15, 2017.

Biospecimen Research Methods is a UBCx online professional education course offered from http://www.edx.org. This course will help you transform the quality of your research by teaching you the biobanking best practices to collect, store and use human biospecimens in the laboratory.

This course is designed for researchers including graduate and undergraduate students, postdoctoral fellows, pathology residents and research technicians who work with human biospecimens.

Over 6 weeks, professionals with extensive experience in biobanking from the University of British Columbia and the British Columbia Cancer Agency will teach you the international best practices for biobanking and research involving human biospecimens, based on National Cancer Institute (NCI) and International Society of Biological Environmental Repositories standards (ISBER).

What you’ll learn

  • Develop the knowledge to better collect and process human biospecimens to enhance research credibility
  • How to plan a successful research study using biospecimens
  • How to properly store and manage biospecimen data
  • Understand the ethical and privacy issues related to biobanking
  • Gain applicable hands on techniques related to informed consent, data queries, biospecimen collection and storage

Learn more about  Biospecimen Research Methods and enroll today!

www.edx.org/course/biospecimen-research-methods-ubcx-biobank1x

Norma Auger Education Fund – Applications due May 2017

The goal of the C17 Norma Auger Education Fund is to support health professionals involved in pediatric Oncology/Hematology/BMT across Canada advance their knowledge, skills and experience and to promote presentations and knowledge translation by these health professionals.

This is an annual scholarship offered by the C17 Education Committee with funding from the Childhood Cancer Canada Foundation and the Coast to Coast Against Cancer Foundation.
Eligibility:  Non-MD Pediatric Oncology/Hematology/BMT health care professionals working in Canada.

Application deadline: Monday, May 8, 2017.

Application forms can be downloaded HERE.

Travel conference funds for non-MD Canadian health care professionals: 2016 17 Norma Auger Education Fund applications due November 1

Application form: 2016 Norma Auger Application

The goal of the C17 Norma Auger Education Fund is to support health professionals involved in pediatric Oncology/Hematology/BMT across Canada advance their knowledge, skills and experience and to promote presentations and knowledge translation by these health professionals.  This is an annual scholarship offered by the C17 Education Committee with funding from the Childhood Cancer Canada Foundation and the Coast to Coast Against Cancer Foundation.

Eligibility:  Non-MD Pediatric Oncology/Hematology/BMT health care professionals working in Canada.

Application deadline:  Tuesday, November 1, 2016.

Selection Process: Applications will be reviewed by the C17 Education Committee.  Successful applicants will be notified in writing.